Acorda Therapeutics, Inc. ACOR
0.66 +0.66
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 117.63M | 118.57M | 129.07M | 152.97M | 192.41M | |
| 117.63M | 118.57M | 129.07M | 152.97M | 192.41M | |
| 15.28M | 30.33M | 40.79M | 33.51M | 34.85M | |
| 102.35M | 88.23M | 88.28M | 119.45M | 157.56M | |
| 376.94M | 130.27M | 165.58M | 268.38M | 556.13M | |
| 5.15M | 5.80M | 10.42M | 23.01M | 60.08M | |
| 89.70M | 106.26M | 124.40M | 152.58M | 192.85M | |
| -274.59M | -42.04M | -77.30M | -148.92M | -398.57M | |
| 31.53M | 30.20M | 30.04M | 30.57M | 21.87M | |
| -43.17M | 30.67M | -5.12M | -8.07M | -1.28M | |
| -252.85M | -65.92M | -103.95M | -99.59M | -272.97M | |
| -252.85M | -65.92M | -103.95M | -99.59M | -272.97M | |
| -252.85M | -65.92M | -103.95M | -99.59M | -272.97M | |
| -252.85M | -65.92M | -103.95M | -99.59M | -272.97M | |
| -203.57 | -65.23 | -195.80 | -246.40 | -688.60 | |
| -203.57 | -65.23 | -195.80 | -246.40 | -688.60 | |
| -203.57 | -65.23 | -195.80 | -246.40 | -688.60 | |
| -264.49M | -5.05M | -79.04M | -77.09M | -252.38M | |
| -264.49M | -5.05M | -79.04M | -77.09M | -252.38M | |
| 1.24M | 1.01M | 531.05K | 404.20K | 396.35K | |
| 1.24M | 1.01M | 531.05K | 404.20K | 396.35K |